Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Argireline structure

Argireline

Cosmetic & Sexual
Phase 3 Research
60%
Low Risk
1/5

Dosing Protocol

Typical Dose 100 mg
Range 50 - 100 mg

Pharmacokinetics

Half-Life --
Onset 1.0 days
Peak 30.0 days
Duration 30.0 days
Bioavailability 0%
Primary Route Topical

Administration

Routes Topical
Timing Morning, Evening

Special Instructions

Topical only - apply to clean, dry skin on expression lines (forehead, around eyes). Limited skin penetration (<0.2%). Best results with 10% concentration. Often combined with other cosmetic peptides.